KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Change in Cash (2017 - 2025)

Twist Bioscience (TWST) has disclosed Change in Cash for 9 consecutive years, with -$34.4 million as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 578.89% to -$34.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$73.1 million through Dec 2025, down 62.18% year-over-year, with the annual reading at -$43.7 million for FY2025, 27.34% up from the prior year.
  • Change in Cash for Q4 2025 was -$34.4 million at Twist Bioscience, down from -$18.5 million in the prior quarter.
  • The five-year high for Change in Cash was $216.0 million in Q1 2022, with the low at -$274.2 million in Q4 2021.
  • Average Change in Cash over 5 years is -$10.0 million, with a median of -$10.3 million recorded in 2021.
  • The sharpest move saw Change in Cash skyrocketed 327.39% in 2022, then crashed 1396.73% in 2024.
  • Over 5 years, Change in Cash stood at -$274.2 million in 2021, then skyrocketed by 77.69% to -$61.2 million in 2022, then soared by 67.03% to -$20.2 million in 2023, then surged by 74.84% to -$5.1 million in 2024, then plummeted by 578.89% to -$34.4 million in 2025.
  • According to Business Quant data, Change in Cash over the past three periods came in at -$34.4 million, -$18.5 million, and -$9.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.